tapentadol ER
Selected indexed studies
- Efficacy of tapentadol ER for managing moderate to severe chronic pain. (Pain Physician, 2013) [PMID:23340531]
- Tapentadol. (, 2006) [PMID:30835408]
- Composite measure to assess efficacy/gastrointestinal tolerability of tapentadol ER versus oxycodone CR for chronic pain: pooled analysis of randomized studies. (J Opioid Manag, 2013) [PMID:23709304]
_Worker-drafted node — pending editorial review._
Connections
tapentadol ER is a side effect of
Sources
- Oral hydromorphone extended-release. (2010) pubmed
- Efficacy of tapentadol ER for managing moderate to severe chronic pain. (2013) pubmed
- Tapentadol. (2006) pubmed
- Composite measure to assess efficacy/gastrointestinal tolerability of tapentadol ER versus oxycodone CR for chronic pain: pooled analysis of randomized studies. (2013) pubmed
- Tapentadol-ER for the treatment of diabetic peripheral neuropathy. (2013) pubmed
- Characterizing the Experience of Tapentadol Nonmedical Use: Mixed Methods Study. (2022) pubmed
- Tapentadol extended release for chronic pain patients. (2013) pubmed
- Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial. (2011) pubmed
- Population Pharmacokinetic Modeling of Tapentadol Extended Release (ER) in Healthy Subjects and Patients with Moderate or Severe Chronic Pain. (2016) pubmed
- Tapentadol extended release: in adults with chronic pain. (2012) pubmed